Seelos Therapeutics to Participate in the 2021 Jefferies Virtual Healthcare Conference

Rhea-AI Summary

Seelos Therapeutics, Inc. (Nasdaq: SEEL) will participate in the 2021 Jefferies Virtual Healthcare Conference from June 1-4, 2021. The company's Chairman and CEO, Raj Mehra, Ph.D., is scheduled to present on June 3rd at 10:30am ET and will also hold 1x1 meetings. Seelos focuses on developing novel therapeutics for central nervous system disorders and rare diseases, with key assets targeting serious conditions such as Major Depressive Disorder and Amyotrophic Lateral Sclerosis. Registration for the presentation can be found here.

NEW YORK, May 10, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 2021 Jefferies Virtual Healthcare Conference, June 1-4, 2021.

Raj Mehra, Ph.D., Chairman and CEO, will present on Thursday, June 3rd at 10:30am ET and host 1x1 meetings.

Presentation webcast registration may be accessed here.

For more information: Jefferies Virtual Healthcare Conference

About Seelos Therapeutics

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare diseases. The Company's robust portfolio includes several late-stage clinical assets targeting indications including Acute Suicidal Ideation and Behavior (ASIB) in Major Depressive Disorder (MDD) or Post-Traumatic Stress Disorder (PTSD), amyotrophic lateral sclerosis (ALS), Sanfilippo syndrome, Parkinson's disease, other psychiatric and movement disorders plus orphan diseases.

For more information, please visit our website: http://seelostherapeutics.com, the content of which is not incorporated herein by reference.

Contact Information:

Anthony Marciano
Head of Corporate Communications
Seelos Therapeutics, Inc. (Nasdaq: SEEL)
300 Park Avenue
New York, NY 10022
(646) 293-2136
anthony.marciano@seelostx.com
https://seelostherapeutics.com/
https://twitter.com/seelostx
https://www.linkedin.com/company/seelos

View original content to download multimedia:http://www.prnewswire.com/news-releases/seelos-therapeutics-to-participate-in-the-2021-jefferies-virtual-healthcare-conference-301286872.html

SOURCE Seelos Therapeutics, Inc.

FAQ

What is the date of the Jefferies Virtual Healthcare Conference for Seelos Therapeutics?

Seelos Therapeutics will participate in the Jefferies Virtual Healthcare Conference from June 1-4, 2021.

When will Raj Mehra present at the Jefferies Conference?

Raj Mehra, Ph.D., will present on June 3rd at 10:30am ET.

What is the focus of Seelos Therapeutics?

Seelos Therapeutics focuses on developing therapies for central nervous system disorders and rare diseases.

How can I register for the Seelos presentation at the Jefferies Conference?

You can register for Seelos's presentation at the Jefferies Virtual Healthcare Conference here.

What are the key therapeutic areas for Seelos Therapeutics?

Seelos Therapeutics targets Major Depressive Disorder, Amyotrophic Lateral Sclerosis, and other central nervous system and rare diseases.